Cargando…

Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes

Many enzymes require post-translational modifications or cofactor machinery for primary function. As these catalytically essential moieties are highly regulated, they act as dual sensors and chemical handles for context-dependent metabolic activity. Clostridioides difficile is a major nosocomial pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bustin, Katelyn A., Abbas, Arwa, Wang, Xie, Abt, Michael C., Zackular, Joseph P., Matthews, Megan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908766/
https://www.ncbi.nlm.nih.gov/pubmed/36778002
http://dx.doi.org/10.3389/fphar.2023.1074619
_version_ 1784884434912149504
author Bustin, Katelyn A.
Abbas, Arwa
Wang, Xie
Abt, Michael C.
Zackular, Joseph P.
Matthews, Megan L.
author_facet Bustin, Katelyn A.
Abbas, Arwa
Wang, Xie
Abt, Michael C.
Zackular, Joseph P.
Matthews, Megan L.
author_sort Bustin, Katelyn A.
collection PubMed
description Many enzymes require post-translational modifications or cofactor machinery for primary function. As these catalytically essential moieties are highly regulated, they act as dual sensors and chemical handles for context-dependent metabolic activity. Clostridioides difficile is a major nosocomial pathogen that infects the colon. Energy generating metabolism, particularly through amino acid Stickland fermentation, is central to colonization and persistence of this pathogen during infection. Here using activity-based protein profiling (ABPP), we revealed Stickland enzyme activity is a biomarker for C. difficile infection (CDI) and annotated two such cofactor-dependent Stickland reductases. We structurally characterized the cysteine-derived pyruvoyl cofactors of D-proline and glycine reductase in C. difficile cultures and showed through cofactor monitoring that their activity is regulated by their respective amino acid substrates. Proline reductase was consistently active in toxigenic C. difficile, confirming the enzyme to be a major metabolic driver of CDI. Further, activity-based hydrazine probes were shown to be active site-directed inhibitors of proline reductase. As such, this enzyme activity, via its druggable cofactor modality, is a promising therapeutic target that could allow for the repopulation of bacteria that compete with C. difficile for proline and therefore restore colonization resistance against C. difficile in the gut.
format Online
Article
Text
id pubmed-9908766
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99087662023-02-10 Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes Bustin, Katelyn A. Abbas, Arwa Wang, Xie Abt, Michael C. Zackular, Joseph P. Matthews, Megan L. Front Pharmacol Pharmacology Many enzymes require post-translational modifications or cofactor machinery for primary function. As these catalytically essential moieties are highly regulated, they act as dual sensors and chemical handles for context-dependent metabolic activity. Clostridioides difficile is a major nosocomial pathogen that infects the colon. Energy generating metabolism, particularly through amino acid Stickland fermentation, is central to colonization and persistence of this pathogen during infection. Here using activity-based protein profiling (ABPP), we revealed Stickland enzyme activity is a biomarker for C. difficile infection (CDI) and annotated two such cofactor-dependent Stickland reductases. We structurally characterized the cysteine-derived pyruvoyl cofactors of D-proline and glycine reductase in C. difficile cultures and showed through cofactor monitoring that their activity is regulated by their respective amino acid substrates. Proline reductase was consistently active in toxigenic C. difficile, confirming the enzyme to be a major metabolic driver of CDI. Further, activity-based hydrazine probes were shown to be active site-directed inhibitors of proline reductase. As such, this enzyme activity, via its druggable cofactor modality, is a promising therapeutic target that could allow for the repopulation of bacteria that compete with C. difficile for proline and therefore restore colonization resistance against C. difficile in the gut. Frontiers Media S.A. 2023-01-26 /pmc/articles/PMC9908766/ /pubmed/36778002 http://dx.doi.org/10.3389/fphar.2023.1074619 Text en Copyright © 2023 Bustin, Abbas, Wang, Abt, Zackular and Matthews. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Bustin, Katelyn A.
Abbas, Arwa
Wang, Xie
Abt, Michael C.
Zackular, Joseph P.
Matthews, Megan L.
Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes
title Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes
title_full Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes
title_fullStr Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes
title_full_unstemmed Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes
title_short Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes
title_sort characterizing metabolic drivers of clostridioides difficile infection with activity-based hydrazine probes
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908766/
https://www.ncbi.nlm.nih.gov/pubmed/36778002
http://dx.doi.org/10.3389/fphar.2023.1074619
work_keys_str_mv AT bustinkatelyna characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes
AT abbasarwa characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes
AT wangxie characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes
AT abtmichaelc characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes
AT zackularjosephp characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes
AT matthewsmeganl characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes